Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.

Tsuchiyama K, Ito H, Taga M, Naganuma S, Oshinoya Y, Nagano K, Yokoyama O, Itoh H.

Prostate. 2013 Jun;73(8):827-34. doi: 10.1002/pros.22626. Epub 2012 Nov 26.

PMID:
23184537
2.

Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel.

Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, Liu P.

Cancer Chemother Pharmacol. 2013 May;71(5):1159-71. doi: 10.1007/s00280-013-2108-y. Epub 2013 Feb 20.

PMID:
23423488
3.

The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.

Albonico F, Mortarino M, Avallone G, Gioia G, Comazzi S, Roccabianca P.

Vet Immunol Immunopathol. 2013 Sep 1;155(1-2):117-23. doi: 10.1016/j.vetimm.2013.06.018. Epub 2013 Jul 3.

PMID:
23871213
4.

Regulation of expression of deoxyhypusine hydroxylase (DOHH), the enzyme that catalyzes the activation of eIF5A, by miR-331-3p and miR-642-5p in prostate cancer cells.

Epis MR, Giles KM, Kalinowski FC, Barker A, Cohen RJ, Leedman PJ.

J Biol Chem. 2012 Oct 12;287(42):35251-9. doi: 10.1074/jbc.M112.374686. Epub 2012 Aug 20.

5.

Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.

PMID:
23741026
6.

Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis.

Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sañudo A, Antunes AA, Srougi M.

Urol Oncol. 2011 May-Jun;29(3):265-9. doi: 10.1016/j.urolonc.2009.02.002. Epub 2009 Apr 16.

PMID:
19372056
7.

MicroRNA miR-17-5p is overexpressed in pancreatic cancer, associated with a poor prognosis, and involved in cancer cell proliferation and invasion.

Yu J, Ohuchida K, Mizumoto K, Fujita H, Nakata K, Tanaka M.

Cancer Biol Ther. 2010 Oct 15;10(8):748-57. doi: 10.4161/cbt.10.8.13083. Epub 2010 Oct 15.

PMID:
20703102
8.

MicroRNA expression profiles in the progression of prostate cancer--from high-grade prostate intraepithelial neoplasia to metastasis.

Leite KR, Tomiyama A, Reis ST, Sousa-Canavez JM, Sañudo A, Camara-Lopes LH, Srougi M.

Urol Oncol. 2013 Aug;31(6):796-801. doi: 10.1016/j.urolonc.2011.07.002. Epub 2011 Aug 30.

PMID:
21880514
9.

Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells.

Östling P, Leivonen SK, Aakula A, Kohonen P, Mäkelä R, Hagman Z, Edsjö A, Kangaspeska S, Edgren H, Nicorici D, Bjartell A, Ceder Y, Perälä M, Kallioniemi O.

Cancer Res. 2011 Mar 1;71(5):1956-67. doi: 10.1158/0008-5472.CAN-10-2421. Epub 2011 Feb 22.

10.
11.

Expression of microRNAs in basal cell carcinoma.

Sand M, Skrygan M, Sand D, Georgas D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

Br J Dermatol. 2012 Oct;167(4):847-55. doi: 10.1111/j.1365-2133.2012.11022.x. Epub 2012 Aug 20.

PMID:
22540308
12.

MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma.

Won KY, Kim YW, Kim HS, Lee SK, Jung WW, Park YK.

Hum Pathol. 2013 Aug;44(8):1648-55. doi: 10.1016/j.humpath.2013.01.016. Epub 2013 Apr 8.

PMID:
23574781
13.

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.

BMC Cancer. 2010 Jun 22;10:318. doi: 10.1186/1471-2407-10-318.

14.

Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC.

Kimura S, Naganuma S, Susuki D, Hirono Y, Yamaguchi A, Fujieda S, Sano K, Itoh H.

Oncol Rep. 2010 Jun;23(6):1625-33.

PMID:
20428818
15.

Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.

Song C, Chen H, Wang T, Zhang W, Ru G, Lang J.

Prostate. 2015 Apr 1;75(5):500-16. doi: 10.1002/pros.22936. Epub 2015 Jan 16.

PMID:
25597612
16.

[Correlations between miRNAs and TGF-β1 in tumor microenvironment of esophageal squamous cell cancer].

Zhu L, Jin L, Jiang R, Wang Q, Jiang J, Mao C, Chen D.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013 May;29(5):524-8. Chinese.

PMID:
23643275
17.

Stromal expression of MiR-21 predicts biochemical failure in prostate cancer patients with Gleason score 6.

Melbø-Jørgensen C, Ness N, Andersen S, Valkov A, Dønnem T, Al-Saad S, Kiselev Y, Berg T, Nordby Y, Bremnes RM, Busund LT, Richardsen E.

PLoS One. 2014 Nov 17;9(11):e113039. doi: 10.1371/journal.pone.0113039. eCollection 2014.

18.

miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progression.

Fendler A, Jung M, Stephan C, Honey RJ, Stewart RJ, Pace KT, Erbersdobler A, Samaan S, Jung K, Yousef GM.

Int J Oncol. 2011 Nov;39(5):1183-92. doi: 10.3892/ijo.2011.1128. Epub 2011 Jul 18.

PMID:
21769427
19.

MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.

Lee H, Kim KR, Cho NH, Hong SR, Jeong H, Kwon SY, Park KH, An HJ, Kim TH, Kim I, Yoon HK, Suh KS, Min KO, Choi HJ, Park JY, Yoo CW, Lee YS, Lee HJ, Lee WS, Park CS, Lee Y; Gynecological Pathology Study Group of the Korean Society of Pathologists..

World J Surg Oncol. 2014 Nov 8;12:334. doi: 10.1186/1477-7819-12-334.

20.

MiR-361-5p acts as a tumor suppressor in prostate cancer by targeting signal transducer and activator of transcription-6(STAT6).

Liu D, Tao T, Xu B, Chen S, Liu C, Zhang L, Lu K, Huang Y, Jiang L, Zhang X, Huang X, Zhang L, Han C, Chen M.

Biochem Biophys Res Commun. 2014 Feb 28;445(1):151-6. doi: 10.1016/j.bbrc.2014.01.140. Epub 2014 Jan 31.

PMID:
24491557

Supplemental Content

Support Center